<DOC>
	<DOCNO>NCT02805179</DOCNO>
	<brief_summary>This study determine safety effectiveness high-dose radiation therapy ( RT ) concurrent temozolomide patient newly diagnose glioblastoma .</brief_summary>
	<brief_title>A Study High-Dose Chemoradiation Using Biologically-Based Target Volume Definition Patients With Glioblastoma</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Newly diagnose histologicallyconfirmed supratentorial World Health Organization ( WHO ) grade IV glioma include glioblastoma multiforme gliosarcoma Age 18 old Karnofsky performance status ( measure quantify general well activity daily life ; scale range 0 100 100 perfect health ) great equal 70 Life expectancy least 12 week Adequate bone marrow reserve ( hemoglobin great equal 10 , absolute neutrophil count great equal 1500 , platelet great equal 100,000 ) ; acceptable liver function ( total bilirubin less equal 2.0 mg/dl , ALT ( Alanine Aminotransferase ) /AST ( Aspartate Aminotransferase ) less equal 5 time normal range ) ; acceptable renal function ( serum creatinine less equal 2.0 mg/dl ) . Eligibility level hemoglobin may reach transfusion . Maximal contiguous volume tumor base high bvalue diffusion MRI &lt; 1/3 volume brain Patients must register within 6 week recent resection . Patients must sign studyspecific inform consent . Recurrent glioma , tumor involve brainstem cerebellum . Prior lowgrade glioma without prior RT , malignant progression eligible . Prior use Gliadel wafer intratumoral intracavitary treatment permit . Prior chemotherapy different cancer allowable , except Temozolomide Bevacizumab . Evidence cerebrospinal fluid dissemination ( positive cerebrospinal fluid cytology malignancy MRI finding consistent CSF dissemination ) Evidence severe concurrent disease require treatment Prior invasive malignancy ( except nonmelanoma skin cancer ) unless diseasefree minimum 3 year ( example , carcinoma situ breast , oral cavity cervix permissible ) Patients unable undergo Magnetic Resonance Imaging exam ( MRI ) ( i.e . patient noncompatible device cardiac pacemaker , implant electronic device , metallic prosthesis , ferromagnetic prosthesis ( e.g . pin artificial joint surgical pins/clips ) unable receive gadolinium MRI , per standard UM Department Radiology MRI screen criterion ) Patients treat previous cranial head/neck radiotherapy lead radiation field overlap Females childbearing potential must negative pregnancy test within 14 day prior registration . Patients reproductive potential must agree use effective contraceptive method treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>